Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 81351-81400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05482386
STREAM Trial - Biomarker
NARecruiting
500 participants
Started: Nov 21, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT05436535
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
PHASE4Active, not recruiting
433 participants
Started: Nov 21, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor10 locations
NCT05556096
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
PHASE3Active, not recruiting
260 participants
Started: Nov 21, 2022 · Completed: Aug 31, 2027
1 condition1 sponsor132 locations
NCT05568095
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
PHASE3Active, not recruiting
1,040 participants
Started: Nov 21, 2022 · Completed: Feb 28, 2027
1 condition3 sponsors210 locations
NCT05548452
Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
PHASE1/PHASE2Recruiting
80 participants
Started: Nov 21, 2022 · Completed: Dec 30, 2026
3 conditions2 sponsors2 locations
NCT05719480
A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer
N/ARecruiting
2,000 participants
Started: Nov 20, 2022 · Completed: Dec 20, 2025
4 conditions1 sponsor1 location
NCT05276076
A Prospective, Open Label, Dose-escalation, SAD/MAD, Multicenter, 24weeks, Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of Investigational Product (VM-001) in Patients With Graft-versus-host Disease(GvHD)
PHASE1/PHASE2Not yet recruiting
12 participants
Started: Nov 20, 2022 · Completed: Nov 20, 2025
1 condition1 sponsor0 locations
NCT05833321
Prospective Study of Detection of Sarcopenia in Clinical Practice for Patient With Ovarian or Endometrial Cancer
NARecruiting
75 participants
Started: Nov 20, 2022 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT05621707
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)
PHASE2Not yet recruiting
50 participants
Started: Nov 20, 2022 · Completed: Nov 19, 2026
4 conditions1 sponsor0 locations
NCT05197309
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
NARecruiting
20 participants
Started: Nov 20, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05381649
Empathy Anomalies in Emotionally Unstable (Borderline) Personality Disorder
N/AActive, not recruiting
30 participants
Started: Nov 20, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05632887
The Effect of Eyeliner on Tear Composition, Tear Secretion and Tear Film Stability.
N/ARecruiting
80 participants
Started: Nov 20, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05871099
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
PHASE3Recruiting
616 participants
Started: Nov 20, 2022 · Completed: Nov 20, 2039
1 condition23 sponsors1 location
NCT05579678
APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation
N/ARecruiting
45 participants
Started: Nov 20, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05607927
PE-Bacon for Late Complications of Chronic Radiation-induced Rectal Injury
PHASE3Not yet recruiting
316 participants
Started: Nov 20, 2022 · Completed: Aug 30, 2028
1 condition1 sponsor0 locations
NCT05783401
Digital Voice Analysis as a Measure of Frailty and Distress
N/ARecruiting
100 participants
Started: Nov 19, 2022 · Completed: Nov 30, 2025
2 conditions1 sponsor2 locations
NCT05550064
Structured Contraceptive Counseling During Pregnancy
NARecruiting
160 participants
Started: Nov 19, 2022 · Completed: Dec 31, 2026
5 conditions1 sponsor4 locations
NCT05613283
Primary Cervical Cancer Screening by Self-sampling HPV Test
N/AActive, not recruiting
17,875 participants
Started: Nov 19, 2022 · Completed: Aug 31, 2027
17 conditions3 sponsors6 locations
NCT05550740
Repeated Low-Level Red-Light Therapy for Shortening Axial Length
NAActive, not recruiting
30 participants
Started: Nov 19, 2022 · Completed: Mar 23, 2026
3 conditions1 sponsor1 location
NCT05320263
Contact Aspiration Versus Stent Retriever for Recanalisation of Acute Stroke Patients With Basilar Artery Occlusion: The Posterior Circulation ASTER Randomized Trial Protocol
NARecruiting
480 participants
Started: Nov 19, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor12 locations
NCT05630950
LDCT-SC-FI Low-dose CT Screening for Lung Cancer
NAActive, not recruiting
200 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT04756843
Early Orthodontic Treatment of Dental Crowding
NAActive, not recruiting
60 participants
Started: Nov 18, 2022 · Completed: Jan 31, 2030
1 condition2 sponsors1 location
NCT05408260
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer
NARecruiting
30 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05641519
Skills-Based Educational Strategies for Reduction of Vascular Events in Orange County
NAActive, not recruiting
483 participants
Started: Nov 18, 2022 · Completed: Jul 31, 2026
1 condition7 sponsors1 location
NCT05261516
Interaction of Volatile Anesthetics With Magnesium
PHASE4Recruiting
96 participants
Started: Nov 18, 2022 · Completed: Aug 31, 2025
1 condition3 sponsors1 location
NCT05465629
Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions
NARecruiting
150 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05510115
Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
PHASE2Active, not recruiting
50 participants
Started: Nov 18, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05429827
The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome
NARecruiting
30 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05349240
C2 Esophageal Squamous Epithelium Dysplasia
NARecruiting
129 participants
Started: Nov 18, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor4 locations
NCT05402813
Natural History in Children Up to 16 Years with Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes
N/ARecruiting
180 participants
Started: Nov 18, 2022 · Completed: Nov 18, 2028
7 conditions1 sponsor1 location
NCT06138717
The Effect of Aerobic Exercises and Yoga Exercises in Axial Spondyloarthritis
NARecruiting
60 participants
Started: Nov 18, 2022 · Completed: Jan 15, 2024
1 condition1 sponsor1 location
NCT06137820
CETI-ANKLE: Cetilar®️ in Patients With Ankle Injury or Chronic Trauma to the Ankle
NAActive, not recruiting
80 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2023
1 condition2 sponsors3 locations
NCT05734001
Rotational Thromboelastometry Versus Conventional Haemostatic Tests in Children With Decompensated Cirrhosis Undergoing Invasive Procedures.
NARecruiting
90 participants
Started: Nov 18, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT05468489
To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
PHASE3Active, not recruiting
200 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor67 locations
NCT06735989
Moral Reasoning Intervention on Moral Justification Abilities
NAActive, not recruiting
150 participants
Started: Nov 18, 2022 · Completed: Feb 28, 2025
4 conditions2 sponsors1 location
NCT05614063
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
PHASE3Active, not recruiting
360 participants
Started: Nov 18, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors127 locations
NCT05495464
"A Pilot Window-3 Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma"
EARLY_PHASE1Active, not recruiting
22 participants
Started: Nov 18, 2022 · Completed: Mar 31, 2027
2 conditions3 sponsors1 location
NCT05731440
Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease
N/AActive, not recruiting
60 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05436418
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
PHASE1/PHASE2Recruiting
260 participants
Started: Nov 18, 2022 · Completed: Jul 2, 2027
2 conditions1 sponsor2 locations
NCT05621902
Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer
NANot yet recruiting
398 participants
Started: Nov 18, 2022 · Completed: Jun 30, 2027
1 condition3 sponsors0 locations
NCT05633498
Self-help Book for Shift Work Related Problems
NARecruiting
300 participants
Started: Nov 18, 2022 · Completed: Mar 18, 2025
1 condition1 sponsor1 location
NCT04692675
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NARecruiting
508 participants
Started: Nov 18, 2022 · Completed: Sep 1, 2031
1 condition1 sponsor1 location
NCT06952452
Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)
PHASE3Recruiting
630 participants
Started: Nov 18, 2022 · Completed: Jul 31, 2026
1 condition2 sponsors3 locations
NCT06319742
Extracellular Vesicle Surface Markers In Acute Cerebrovascular Syndromes.
N/ARecruiting
200 participants
Started: Nov 18, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05649072
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
NARecruiting
1,000 participants
Started: Nov 18, 2022 · Completed: Feb 2, 2027
3 conditions2 sponsors1 location
NCT06117566
A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
100 participants
Started: Nov 18, 2022 · Completed: Nov 9, 2025
1 condition1 sponsor1 location
NCT06078462
Impact of Job Related Activities on Female Physiotherapist and Dentist During Internship Year
N/ARecruiting
100 participants
Started: Nov 18, 2022 · Completed: Dec 30, 2023
1 condition1 sponsor2 locations
NCT05464121
A Blended Intervention for Adjustment Disorder.
NARecruiting
41 participants
Started: Nov 18, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06259162
LAG3 Expression in Triple Negative Breast Cancer
NARecruiting
128 participants
Started: Nov 18, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05673252
CERvical Cancer The InFlammatory Index (CERTIFIKO)
N/ARecruiting
128 participants
Started: Nov 18, 2022 · Completed: Nov 18, 2024
1 condition1 sponsor1 location